Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 5

Results: 15

Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 861, doi. 10.1007/s00262-019-02336-6

By:

Sanchez-Correa, Beatriz;
Lopez-Sejas, Nelson;
Duran, Esther;
Labella, Fernando;
Alonso, Corona;
Solana, Rafael;
Tarazona, Raquel

Publication type:

Article

T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 705, doi. 10.1007/s00262-019-02335-7

By:

Baxevanis, Constantin N.

Publication type:

Article

Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 743, doi. 10.1007/s00262-019-02316-w

By:

Faiena, Izak;
Astrow, Stephanie H.;
Elashoff, David A.;
Jain, Rajul;
Bot, Adrian;
Chamie, Karim;
Belldegrun, Arie S.;
Pantuck, Allan J.;
Drakaki, Alexandra

Publication type:

Article

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 799, doi. 10.1007/s00262-019-02315-x

By:

Sebastian, Martin;
Schröder, Andreas;
Scheel, Birgit;
Hong, Henoch S.;
Muth, Anke;
von Boehmer, Lotta;
Zippelius, Alfred;
Mayer, Frank;
Reck, Martin;
Atanackovic, Djordje;
Thomas, Michael;
Schneller, Folker;
Stöhlmacher, Jan;
Bernhard, Helga;
Gröschel, Andreas;
Lander, Thomas;
Probst, Jochen;
Strack, Tanja;
Wiegand, Volker;
Gnad-Vogt, Ulrike

Publication type:

Article

Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 731, doi. 10.1007/s00262-019-02314-y

By:

Xiong, Ying;
Liu, Li;
Xia, Yu;
Qi, Yangyang;
Chen, Yifan;
Chen, Lingli;
Zhang, Peipei;
Kong, Yunyi;
Qu, Yang;
Wang, Zewei;
Lin, Zhiyuan;
Chen, Xiang;
Xiang, Zhuoyi;
Wang, Jiajun;
Bai, Qi;
Zhang, Weijuan;
Yang, Yuanfeng;
Guo, Jianming;
Xu, Jiejie

Publication type:

Article

Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 787, doi. 10.1007/s00262-019-02313-z

By:

Werter, Inge M.;
Huijts, Charlotte M.;
Lougheed, Sinéad. M.;
Hamberg, Paul;
Polee, Marco B.;
Tascilar, Metin;
Los, Maartje;
Haanen, John B. A. G.;
Helgason, Helgi H.;
Verheul, Henk M.;
de Gruijl, Tanja D.;
van der Vliet, Hans J.

Publication type:

Article

Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 721, doi. 10.1007/s00262-019-02312-0

By:

Aronov, Dmitry A.;
Zhukov, Viacheslav V.;
Semushina, Svetlana G.;
Moiseeva, Ekaterina V.

Publication type:

Article

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 765, doi. 10.1007/s00262-019-02311-1

By:

Schilling, Bastian;
Martens, Alexander;
Geukes Foppen, Marnix H.;
Gebhardt, Christoffer;
Hassel, Jessica C.;
Rozeman, Elisa A.;
Gesierich, Anja;
Gutzmer, Ralf;
Kähler, Katharina C.;
Livingstone, Elisabeth;
Diamantopoulos, Panagiotis T.;
Gogas, Helen;
Madonna, Gabriele;
Ascierto, Paolo A.;
Goldinger, Simone M.;
Mangana, Johanna;
Garbe, Claus;
Schadendorf, Dirk;
Blank, Christian;
Weide, Benjamin

Publication type:

Article

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 773, doi. 10.1007/s00262-019-02307-x

By:

Nguyen, Linh T.;
Saibil, Samuel D.;
Sotov, Valentin;
Le, Michael X.;
Khoja, Leila;
Ghazarian, Danny;
Bonilla, Luisa;
Majeed, Habeeb;
Hogg, David;
Joshua, Anthony M.;
Crump, Michael;
Franke, Norman;
Spreafico, Anna;
Hansen, Aaron;
Al-Habeeb, Ayman;
Leong, Wey;
Easson, Alexandra;
Reedijk, Michael;
Goldstein, David P.;
McCready, David

Publication type:

Article

Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 753, doi. 10.1007/s00262-018-02297-2

By:

Silva, Jamile R.;
Sales, Natiely S.;
Silva, Mariângela O.;
Aps, Luana R. M. M.;
Moreno, Ana C. R.;
Rodrigues, Elaine G.;
Ferreira, Luís C. S.;
Diniz, Mariana O.

Publication type:

Article

Natural T cell autoreactivity to melanoma antigens: clonally expanded melanoma-antigen specific CD8 + memory T cells can be detected in healthy humans.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 709, doi. 10.1007/s00262-018-02292-7

By:

Przybyla, Anna;
Zhang, Ting;
Li, Ruliang;
Roen, Diana R.;
Mackiewicz, Andrzej;
Lehmann, Paul V.

Publication type:

Article

An alphavirus-based therapeutic cancer vaccine: from design to clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 849, doi. 10.1007/s00262-018-2276-z

By:

Singh, Amrita;
Koutsoumpli, Georgia;
van de Wall, Stephanie;
Daemen, Toos

Publication type:

Article

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 835, doi. 10.1007/s00262-018-2269-y

By:

Zhu, Jingjing;
Petit, Pierre-Florent;
Van den Eynde, Benoit J.

Publication type:

Article

Opposing roles of eosinophils in cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 823, doi. 10.1007/s00262-018-2255-4

By:

Simon, Sonja C. S.;
Utikal, Jochen;
Umansky, Viktor

Publication type:

Article

Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 813, doi. 10.1007/s00262-018-2229-6

By:

Dimitrakopoulou-Strauss, Antonia

Publication type:

Article